Drug Shortage Report for TEVA-TELMISARTAN

Last updated on 2020-09-03 History
Report ID 120282
Drug Identification Number 02320185
Brand name TEVA-TELMISARTAN
Common or Proper name TELMISARTAN 80MG TAB
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) TELMISARTAN
Strength(s) 80MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 500's a P/pack 30's
ATC code C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Shortage of an inactive ingredient or component.
Anticipated start date
Actual start date 2020-07-14
Estimated end date 2020-12-31
Actual end date 2020-09-02
Shortage status Resolved
Updated date 2020-09-03
Company comments Allocating to 100% of the Teva market for the duration if the risk period.
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2020-09-03 French Compare
v4 2020-09-03 English Compare
v3 2020-07-15 English Compare
v2 2020-07-14 French Compare
v1 2020-07-14 English Compare